Literature DB >> 16465925

Surveillance of Shiga toxigenic Escherichia coli in Australia.

Barry G Combs1, Jane C A Raupach, Martyn D Kirk.   

Abstract

All Australian States and Territories have low rates (< or = 0.32 cases per 100,000 population) of notification for Shiga toxin-producing Escherichia coli (STEC), except for South Australia where the rates are ten-fold higher at 2.58 cases per 100,000 population. To explore possible reasons for the variation in rates we surveyed public health reference laboratories to determine the methods used and number of specimens tested for these organisms. Only five of eight jurisdictions routinely conducted testing for STEC, and polymerase chain based tests were most common. Culture was also common and in one jurisdiction that tests specimens with culture, approximately 1.2 per cent of specimens were positive. The notification rates for different jurisdictions reflected the number of specimens tested, with jurisdiction testing < or = 500 specimens having rates < or = 0.32 cases per 100,000 population. The use of culture as a test method may also influence notification rates. Public health agencies must consider the number of specimens tested in interpreting surveillance data.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16465925

Source DB:  PubMed          Journal:  Commun Dis Intell Q Rep        ISSN: 1447-4514


  4 in total

Review 1.  An overview of the epidemiology of notifiable infectious diseases in Australia, 1991-2011.

Authors:  K B Gibney; A C Cheng; R Hall; K Leder
Journal:  Epidemiol Infect       Date:  2016-06-22       Impact factor: 4.434

2.  Epidemiology of Shiga toxin producing Escherichia coli in Australia, 2000-2010.

Authors:  Hassan Vally; Gillian Hall; Amalie Dyda; Jane Raupach; Katrina Knope; Barry Combs; Patricia Desmarchelier
Journal:  BMC Public Health       Date:  2012-01-21       Impact factor: 3.295

3.  Estimating community incidence of Salmonella, Campylobacter, and Shiga toxin-producing Escherichia coli infections, Australia.

Authors:  Gillian Hall; Keflemariam Yohannes; Jane Raupach; Niels Becker; Martyn Kirk
Journal:  Emerg Infect Dis       Date:  2008-10       Impact factor: 6.883

4.  The antimicrobial activity of probiotic bacteria Escherichia coli isolated from different natural sources against hemorrhagic E. coli O157:H7.

Authors:  Sahar Karimi; Fatemeh Azizi; Mohammad Nayeb-Aghaee; Leila Mahmoodnia
Journal:  Electron Physician       Date:  2018-03-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.